Loading organizations...
Loading organizations...
Biotechnology company developing treatments for inflammatory diseases.
Atom Bioscience & Pharmaceutical has raised $127.1M across 2 funding rounds.
Atom Bioscience & Pharmaceutical has raised $127.1M in total across 2 funding rounds.
Atom Bioscience & Pharmaceutical has raised $127.1M in total across 2 funding rounds.
Atom Bioscience & Pharmaceutical's investors include Kaitai Capital, Fortune Capital, Huajin Investment, Yuhang Teng, Huang Pu, Efung Capital, Hongshan Capital Group (Sequoia Capital China), Livzon Pharmaceutical Group, Unifortune Investment Holdings Group.
Atom Bioscience & Pharmaceutical has raised $127.1M across 2 funding rounds. Most recently, it raised $82.1M Series D in October 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 16, 2023 | $82.1M Series D | Kaitai Capital | Fortune Capital, Huajin Investment |
| Jan 5, 2022 | $45.0M Series C | Yuhang Teng, Huang Pu | Efung Capital, Hongshan Capital Group (Sequoia Capital China), Kaitai Capital, Livzon Pharmaceutical Group, Unifortune Investment Holdings Group |